The percentage of patients hesitant to undergo plastic surgery with surgeons compensated under alternative payment models increased after they learned how the arrangements work.


By Alyx Arnett

Patients may become more hesitant about undergoing plastic surgery when they learn about the financial incentives built into certain surgeon reimbursement arrangements, according to a new study.

The study examined patients’ perceptions of alternative payment models, which tie physician compensation to factors such as the cost and quality of care rather than relying solely on traditional fee-for-service reimbursement.

Justin M. Broyles, MD, MPH, of the Division of Plastic Surgery at Brigham and Women’s Hospital and assistant professor of surgery at Harvard Medical School.

“While alternative payment models are intended to improve quality and control costs, relatively little attention has been paid to whether patients understand or trust these arrangements,” says study co-author Justin M. Broyles, MD, MPH, of the Division of Plastic Surgery at Brigham and Women’s Hospital and assistant professor of surgery at Harvard Medical School.

Among the 264 plastic surgery patients surveyed, just 7.6% were initially aware of alternative payment models. After receiving information about the models, the percentage of patients hesitant to undergo surgery with a surgeon compensated under one rose from 13% to 38%. 

In this Research Q&A, Broyles discusses what the findings reveal about patient trust, how financial incentives influence perceptions of care, and what the results could mean for plastic surgeons as reimbursement models evolve.

[Editor’s note: Read the study, “Patient perspectives on alternative payment models in plastic surgery,” in Journal of Surgical Research.]

PSP: What do your findings reveal about patients’ understanding of alternative payment models?

Our findings suggest that patients have a limited understanding of physician reimbursement models. More importantly, once patients learned how alternative payment models work, their perceptions changed, particularly regarding financial incentives and how those incentives might influence clinical decisions.

PSP: Were any of the findings surprising?

What stood out was that greater awareness of alternative payment models did not necessarily translate into greater acceptance. Despite their potential benefits, patients appeared concerned that financial incentives could influence decisions about their care—particularly true when it came to the perception of rationing.  

PSP: What do you think explains these reactions?

Patients understandably want to know that their surgeon’s decisions are driven by what is best for them, rather than financial considerations. When cost reduction becomes part of the reimbursement structure, patients may worry that necessary care could be compromised, even when these models are designed to improve overall value.

PSP: Patients placed greater importance on complication rates, revision costs, and cost transparency after learning about alternative payment models. What does this suggest about their priorities when choosing a plastic surgeon?

Patients clearly value quality, safety, and transparency. They want to understand not only the initial cost of surgery but also the potential financial and clinical consequences of complications or additional procedures. These are important considerations that should be central to how we measure value in plastic surgery.

PSP: What are the implications of these findings for plastic surgeons?

The takeaway is that transparency matters. Surgeons should be prepared to discuss expected outcomes, complication risks, and potential costs openly with patients. As reimbursement models evolve, maintaining patient trust requires demonstrating that quality of care remains the primary priority.

PSP: What further research is needed to understand patient attitudes toward alternative payment models and their potential role in plastic surgery?

Broadening awareness of how healthcare is paid for and how this influences physician behavior will make for a more educated patient. This is particularly germane to plastic surgery, where there is a lot of patient preference in outcome, and many devices which are less well-validated. Future research will be similar to that of other consumer-driven research, where physicians and patients will be given information about new devices and test whether or not they would use them in various reimbursement schemes.  

ID 76061868 © Denisismagilov | Dreamstime.com

Do you want your research featured in an upcoming Research Q&A? Email [email protected].